Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

Videos

Dr Vladimir Maletic on Defining and Responding to Complex ADHD
Videos
Dr Vladimir Maletic on Defining and Responding to Complex ADHD
03/01/2021
In this video, Psych Congress Steering Committee member Vladimir Maletic, MD, MS, discusses the concept of complex attention/deficit-hyperactivity disorder, how it is defined, and how to respond to it.
In this video, Psych Congress Steering Committee member Vladimir Maletic, MD, MS, discusses the concept of complex attention/deficit-hyperactivity disorder, how it is defined, and how to respond to it.
In this video, Psych Congress...
03/01/2021
Psych Congress Network

Advertisement

Recent Developments in Genetic Studies Examining ADHD
Videos
Recent Developments in Genetic Studies Examining ADHD
02/22/2021
Psych Congress Steering Committee member Vladimir Maletic, MD, MS, summarizes some recent findings related to genome‑wide association studies examining attention/deficit-hyperactivity disorder (ADHD).
Psych Congress Steering Committee member Vladimir Maletic, MD, MS, summarizes some recent findings related to genome‑wide association studies examining attention/deficit-hyperactivity disorder (ADHD).
Psych Congress Steering...
02/22/2021
Psych Congress Network
Learning Network Announces Sana Symposium, a Psychedelics-Focused Virtual Education Event
Videos
Learning Network Announces Sana Symposium, a Psychedelics-Focused Virtual Education Event
02/19/2021
With the approval of psychedelic medicines imminent, the Psychiatry & Behavioral Health Learning Network (PBHLN) has announced that its inaugural Sana Symposium will take place Sept. 17-19, 2021.
With the approval of psychedelic medicines imminent, the Psychiatry & Behavioral Health Learning Network (PBHLN) has announced that its inaugural Sana Symposium will take place Sept. 17-19, 2021.
With the approval of psychedelic...
02/19/2021
Psych Congress Network
Dr. Jonathan Alpert on Medical Comorbidities in Patients With Depression
Videos
Dr. Jonathan Alpert on Medical Comorbidities in Patients With Depression
02/19/2021
Jonathan E. Alpert, MD, PhD, of Albert Einstein College of Medicine and Montefiore Medical Center, New York City, New York, discusses the occurrence of medical comorbidities in patients with depression.
Jonathan E. Alpert, MD, PhD, of Albert Einstein College of Medicine and Montefiore Medical Center, New York City, New York, discusses the occurrence of medical comorbidities in patients with depression.
Jonathan E. Alpert, MD, PhD, of...
02/19/2021
Psych Congress Network

Advertisement

Dr Rakesh Jain on Nonstimulant Treatment Options for Pediatric ADHD
Videos
Dr Rakesh Jain on Nonstimulant Treatment Options for Pediatric ADHD
02/17/2021
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses an article he cowrote on nonstimulant treatment options for pediatric attention-deficit/hyperactivity disorder (ADHD).
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses an article he cowrote on nonstimulant treatment options for pediatric attention-deficit/hyperactivity disorder (ADHD).
Psych Congress Steering...
02/17/2021
Psych Congress Network
The Relevance of Noncore Symptoms in Patients With ADHD
Videos
The Relevance of Noncore Symptoms in Patients With ADHD
02/16/2021
In this video, Psych Congress Steering Committee member Vladimir Maletic, MD, MS, discusses the noncore symptoms of attention/deficit-hyperactivity disorder (ADHD) and how they are relevant to diagnosis and treatment.
In this video, Psych Congress Steering Committee member Vladimir Maletic, MD, MS, discusses the noncore symptoms of attention/deficit-hyperactivity disorder (ADHD) and how they are relevant to diagnosis and treatment.
In this video, Psych Congress...
02/16/2021
Psych Congress Network
Genetics-Based Statistical Approach Links ADHD With Childhood Obesity
Videos
Genetics-Based Statistical Approach Links ADHD With Childhood Obesity
02/08/2021
Using a genetics-based statistical approach, researchers from the United Kingdom found attention-deficit/hyperactivity disorder (ADHD) to have a causal effect on childhood obesity and coronary artery disease.
Using a genetics-based statistical approach, researchers from the United Kingdom found attention-deficit/hyperactivity disorder (ADHD) to have a causal effect on childhood obesity and coronary artery disease.
Using a genetics-based...
02/08/2021
Psych Congress Network

Advertisement

Elevating the Treatment of Bipolar Disorder and Schizophrenia: Examining the Role of LAIs
Videos
Elevating the Treatment of Bipolar Disorder and Schizophrenia: Examining the Role of LAIs
01/21/2021
In this video, Leslie Citrome, MD, MPH, discusses the use of long-acting injectable antipsychotics in the treatment of schizophrenia and bipolar disorder.
In this video, Leslie Citrome, MD, MPH, discusses the use of long-acting injectable antipsychotics in the treatment of schizophrenia and bipolar disorder.
In this video, Leslie Citrome,...
01/21/2021
Psych Congress Network
Examining Behavioral Parent Training as an Intervention for Children With ADHD
Videos
Examining Behavioral Parent Training as an Intervention for Children With ADHD
01/20/2021
Tycho Dekkers, PhD, discusses his research on Behavioral Parent Training techniques, which was presented at the recent American Professional Society of ADHD and Related Disorders 2021 Virtual Conference.
Tycho Dekkers, PhD, discusses his research on Behavioral Parent Training techniques, which was presented at the recent American Professional Society of ADHD and Related Disorders 2021 Virtual Conference.
Tycho Dekkers, PhD, discusses...
01/20/2021
Psych Congress Network
A Step Toward Improving Cognition in Patients With Serious Mental Illness
Videos
A Step Toward Improving Cognition in Patients With Serious Mental Illness
01/15/2021
Kristin Bigos, PhD, of Johns Hopkins Medicine, Baltimore, Maryland, discusses research that could advance the development of treatments focused on cognition in people with schizophrenia or other serious mental illness.
Kristin Bigos, PhD, of Johns Hopkins Medicine, Baltimore, Maryland, discusses research that could advance the development of treatments focused on cognition in people with schizophrenia or other serious mental illness.
Kristin Bigos, PhD, of Johns...
01/15/2021
Psych Congress Network

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Advertisement

Advertisement

Sign Up

Psych Congress Network Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use